Serum sex hormone-binding globulin levels show too much variability to be used effectively as a screening marker for insulin resistance in women with polycystic ovary syndrome
Authors:
- Michael H. DahanMDMichael H. Dahan
- Jerald GoldsteinJGJerald Goldstein
- 31 October 2006
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 86 (4) , 934-941
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndromeEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitusFertility and Sterility, 2002
- Acanthosis NigricansJournal of Basic and Clinical Physiology and Pharmacology, 1998
- Hyperinsulinemia and sex hormones in healthy premenopausal women: Relative contribution of obesity, obesity type, and duration of obesityMetabolism, 1998
- Sex hormone-binding globulin and female reproductive functionThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Association of decreased sex hormone binding globulin and cardiovascular risk factors.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Insulin Stimulates Androgen Accumulation in Incubations of Human Ovarian Stroma and ThecaObstetrics & Gynecology, 1984
- SEX‐HORMONE‐BINDING GLOBULINClinical Endocrinology, 1974
- Sex-Hormone-Binding Globulin is an Oestrogen AmplifierNature, 1972